References
- Portugal J R, Alencar A, Brito-Lira L C, Carvalho P. Melanotic meningioma complicated by disseminated intravascular coagulation. Surg Neurol 1984; 21: 275–281
- Bodin D, Martin L, Dubos J, Couvret C, Santini J J, Mercier C. Coagulopathie de consummation et méningiome. Ann Fr Anesth Réanim 1986; 5: 308–311
- Eilertsen K E, Østerud B. Tissue factor: (patho)physiology and cellular biology. Blood Coagul Fibrinolysis 2004; 15: 521–538
- Wada H. Disseminated intravascular coagulation. Clin Chim Acta 2004; 344: 13–21
- Ishimaru K, Hirano H, Yamahata H, Takeshima H, Niiro M, Kuratsu J I. The expression of tissue factor correlates with proliferative ability in meningioma. Oncol Rep 2003; 10: 1133–1137
- Niiro M, Ishimaru K, Hirano H, Yunoue S, Kuratsu J. Clinico-pathological study of meningiomas with haemorrhagic onset. Acta Neurochir 2003; 145: 767–772
- Dragoni F, Mazzucconi M G, Acqui M, Ferrante L, Rosa G, Mastronardi L. Coagulation study in patients who had undergone surgery for meningioma. Haemostasis 1993; 23: 301–307
- Vukovitch T C, Gabriel A, Schaeffer B, Veitl M, Matula C, Spiss C K. Hemostasis activation in patients undergoing brain tumour surgery. J Neurosurg 1997; 87: 508–511
- Gerlach R, Raabe A, Scharrer I, Meixensberger J, Seifert V. Post-operative hematoma after surgery for intracranial meningiomas: causes, avoidable risk factors and clinical outcome. Neurol Res 2004; 26: 61–66
- Franchini M, Manzato F. Update on the treatment of disseminated intravascular coagulation. Hematology 2004; 9: 81–85
- Taylor F B, Jr, Chang A, Esmon C T, D'Angelo A, Vigano-D'Angelo S, Blick K E. Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J Clin Invest 1987; 79: 918–925
- Dhainaut J F, Laterre P F, Janes J M, et al. Recombinant Human Activated Protein C Worldwide Evaluation in Sepsis (PROWESS) Study Group: Drotrecogin alfa (activated) in treatment of severe sepsis patients with multiorgan dysfunction: data from the PROWESS trial. Intens Care Med 2003; 29: 894–903
- Aoki N, Matsuda T, Saito H, et al. CTC-111-IM Clinical Research Group: a comparative double blind randomized trial of activated protein C and unfractionated heparin in the treatment of disseminated intravascular coagulation. Int J Hematol 2002; 75: 540–547
- Abraham E, Reinhart K, Demeyer I. Efficacy and safety of Tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. JAMA 2003; 290: 238–247
- Karadimov D, Binev K, Nachkov Y, Platikanov V. Use of activated recombinant factor VII (NovoSeven) during neurosurgery. J Neurosurg Anesthesiol 2003; 15: 330–332